Due to the particularity of hormone changes，metabolic changes in vaginal microenvironment and immunological alterations during pregnancy，the increased incidence and recurrence rate of vulvovaginal candidiasis（VVC）in pregnancy has caused heavy socioeconomic burden.It is important to find a proper screening procedure and a reasonable and optimum therapeutic approach，which will be beneficial to decrease the occurrence of adverse outcomes in both mothers and neonates.